Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.

The NIH says funding cuts would save it billions of dollars a year. D.C.-area industry and academic leaders say it would cripple R&D.

“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...

Novotech, a global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to ...

StockNews.com began coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research note issued to investors on Monday morning. The firm issued a sell rating on the stock. Separately ...

U.S. Sen. Jack Reed on Friday hosted a press conference at Butler Hospital in Providence to highlight what he called unlawful ...

Jill Collins, CEO, Chief Strategy Officer, Audacity Health.

Danaher, Recursion Pharmaceuticals, Moderna, Thermo Fisher Scientific, AbbVie, Vertex Pharmaceuticals, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to ...

Fred Hutch Cancer Center oncologist Dr. Peter Nelson, left, explains his lab's research to Congresswoman Suzan DelBene as Dr.

Biotechnology and Microbiology both deal with biological sciences, but the difference between Biotechnology and Microbiology ...